 SAN FRANCISCO, April 8, 2021 PRNewswire -- Sutro Biopharma, Inc. NASDAQ: STRO, a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, today announced that Chief Executive Officer, Bill Newell, will present at two upcoming virtual investor conferences on April 15 and May 5, 2021. Presentation Details 20th Annual Needham Virtual Healthcare Conference Date: Thursday, April 15, 2021 Presentation time: 2:15 p.m. 